It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TMO’s FA Score shows that 1 FA rating(s) are green whileWST’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TMO’s TA Score shows that 3 TA indicator(s) are bullish while WST’s TA Score has 4 bullish TA indicator(s).
TMO (@Medical Specialties) experienced а -0.39% price change this week, while WST (@Medical Specialties) price change was -1.75% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.84%. For the same industry, the average monthly price growth was -9.00%, and the average quarterly price growth was -10.30%.
TMO is expected to report earnings on Oct 25, 2023.
WST is expected to report earnings on Oct 26, 2023.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
|TMO||WST||TMO / WST|
overvalued / fair valued / undervalued
PROFIT vs RISK RATING
PRICE GROWTH RATING
P/E GROWTH RATING
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TMO's Valuation (64) in the Medical Specialties industry is in the same range as WST (86). This means that TMO’s stock grew similarly to WST’s over the last 12 months.
TMO's Profit vs Risk Rating (12) in the Medical Specialties industry is in the same range as WST (23). This means that TMO’s stock grew similarly to WST’s over the last 12 months.
WST's SMR Rating (47) in the Medical Specialties industry is in the same range as TMO (61). This means that WST’s stock grew similarly to TMO’s over the last 12 months.
WST's Price Growth Rating (46) in the Medical Specialties industry is in the same range as TMO (61). This means that WST’s stock grew similarly to TMO’s over the last 12 months.
WST's P/E Growth Rating (14) in the Medical Specialties industry is in the same range as TMO (36). This means that WST’s stock grew similarly to TMO’s over the last 12 months.
2 days ago62%
2 days ago76%
2 days ago67%
2 days ago79%
2 days ago57%
2 days ago46%
2 days ago55%
2 days ago50%
2 days ago53%
2 days ago56%
2 days ago54%
2 days ago54%
6 days ago64%
21 days ago74%
8 days ago58%
2 days ago52%
6 days ago54%
2 days ago82%
2 days ago54%
2 days ago53%
A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.